Variation in microbiome and metabolites is associated with advantageous effects of cholestyramine on primary biliary cholangitis with pruritus
Microbiology Spectrum · 2026
DOI: 10.1128/spectrum.00747-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Yijun Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology, Hangzhou Xixi Hospital affiliated to Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Pruritus, Gastrointestinal Microbiome, Cholestyramine Resin, Liver Cirrhosis, Biliary. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Commission of Zhejiang Province, Hangzhou Municipal Health and Family Planning Commission.
Abstract (Originalsprache)
Emerging evidence implicates bile acid-intestinal microbiota interactions in the pathogenesis of pruritus associated with primary biliary cholangitis (PBC). Cholestyramine, a bile acid sequestrant, is clinically recommended for pruritus alleviation. This study investigates its regulatory effects on gut microbiome composition and metabolite profiles. A prospective cohort of 54 pruritic PBC patients and 25 asymptomatic controls underwent longitudinal multi-omics profiling. Fecal 16S rRNA sequencing and untargeted metabolomics were performed pre-/post-4-week cholestyramine intervention (4 g twice daily). Serum autotaxin, as a biomarker for pruritus assessment, and liver function tests were completed simultaneously. Four important findings were listed as follows. (i) Pruritus phenotype characteristics: Pruritic patients exhibited elevated cholestasis indices (total bilirubin, alkaline phosphatase [ALP], and gamma-glutamyl transferase), higher ATX levels, and increased Gp210 antibody positivity compared to controls (all P < 0.01). Cholestyramine significantly reduced 5-D pruritus scores, ATX levels, and cholestasis markers ( P < 0.01). (ii) Microbial dysbiosis: Gut microbiota diversity (Shannon/Simpson indices) was markedly decreased in pruritic patients, with taxonomic enrichment of Romboutsia , Stenotrophomonas , and Achromobacter , whereas Lachnospiraceae and Bacteroidaceae predominated in controls. (iii) Metabolomic perturbations: Metabolomic analysis identified diminished medium-chain fatty acids and indole derivatives (e.g., norharman) in pruritic patients. (iv) Therapeutic efficacy: Microbial-metabolite-clinical correlations revealed the pivotal role of the Romboutsia -norharman-ATX/ALP axis in the pathogenesis of pruritic PBC. Post-treatment, cholestyramine restored microbial diversity, normalized metabolite levels, and attenuated pruritus. Enterobacteriaceae /long-chain fatty acids have been identified as a significant marker for predicting the efficiency of the response to cholestyramine. IMPORTANCE Pruritus in primary biliary cholangitis arises from synergistic cholestasis and gut microbiome-metabolite dysregulation. Cholestyramine mitigates symptoms by modulating the microbiome-metabolite-host axis, highlighting its therapeutic potential through microbiota remodeling and metabolic homeostasis restoration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatology, Hangzhou Xixi Hospital affiliated to Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
- Department of Dermatology, Zhejiang Province Hospital of Integrated Traditional Chinese and Western Medicine, Hangzhou, Zhejiang, China.
ORCID-Profile: Yijun Zhou, Qiaofei Jin
Förderung
- Health Commission of Zhejiang Province
- Hangzhou Municipal Health and Family Planning Commission
Zitieren
APA
Zhou, Y., Ying, G., Shen, W., Cui, Y., Xiang, B., Jiang, M., Bao, J., & Jin, Q. (2026). Variation in microbiome and metabolites is associated with advantageous effects of cholestyramine on primary biliary cholangitis with pruritus. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00747-25
Vancouver
Zhou Y, Ying G, Shen W, Cui Y, Xiang B, Jiang M, et al. Variation in microbiome and metabolites is associated with advantageous effects of cholestyramine on primary biliary cholangitis with pruritus. Microbiology Spectrum. 2026. doi:10.1128/spectrum.00747-25
BibTeX
@article{Zhou2026,
author = {Zhou, Yijun and Ying, Gaoxiang and Shen, Wei and Cui, Yusheng and Xiang, Bo and Jiang, Muyuan and Bao, Jianfeng and Jin, Qiaofei},
title = {Variation in microbiome and metabolites is associated with advantageous effects of cholestyramine on primary biliary cholangitis with pruritus},
journal = {Microbiology Spectrum},
year = {2026},
doi = {10.1128/spectrum.00747-25}
}
EUVIMED